Vycor Medical, Inc.
VYCO
$0.0679
-$0.0001-0.15%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.66% | -107.84% | -18.97% | 66.85% | 82.79% |
| Total Depreciation and Amortization | 5.10% | 1.80% | 0.49% | -0.33% | -0.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 178.90% | 31.48% | -82.48% | -89.43% | -94.54% |
| Change in Net Operating Assets | 167.03% | 1,756.30% | 506.85% | 1,100.00% | 137.40% |
| Cash from Operations | 104.42% | 1,193.68% | 210.10% | 105.90% | 113.55% |
| Capital Expenditure | 55.32% | -221.88% | -2,450.00% | -235.71% | -235.71% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -66.67% | 66.67% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 55.91% | -229.03% | -1,020.00% | -256.00% | -232.14% |
| Total Debt Issued | -3.33% | -64.10% | -59.20% | -57.59% | -72.42% |
| Total Debt Repaid | -9.06% | 44.53% | 7.68% | 0.92% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,900.00% | -110.39% | -104.36% | -102.04% | -99.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.93% | 141.80% | 565.66% | 88.04% | 137.73% |